Igor D. Bandeira, MD, PhD
@igorbandeira.bsky.social
Brazilian physician-scientist and aspiring psychiatrist. Postdoctoral Research Fellow at Stanford University. Brain Stimulation. Ketamine. Psychedelics.
https://linktr.ee/igordbandeira
https://linktr.ee/igordbandeira
Check out our new commentary in the International Journal of Neuropsychopharmacology (@ijnp.bsky.social) on ketamine–naltrexone clinical trial design for depression.
doi.org/10.1093/ijnp...
doi.org/10.1093/ijnp...
A recent commentary by @igorbandeira.bsky.social et al. highlights the steps in clinical trial design that combine ketamine and naltrexone for major depression, allowing for a mechanistic approach.
@stanfordpsy.bsky.social
#depression #opiod #ketamine #resistantdepression #clinicaltrials
@stanfordpsy.bsky.social
#depression #opiod #ketamine #resistantdepression #clinicaltrials
November 14, 2025 at 7:59 PM
Check out our new commentary in the International Journal of Neuropsychopharmacology (@ijnp.bsky.social) on ketamine–naltrexone clinical trial design for depression.
doi.org/10.1093/ijnp...
doi.org/10.1093/ijnp...
Privileged our mini-panel was selected for #ACNP2026 @acnporg.bsky.social. Grateful to join Drs. J. John Mann (Columbia), Alan Schatzberg (Stanford), Mina Rizk (Mount Sinai) and Yunyu Xiao (Cornell). Looking forward to the discussions ahead!
August 20, 2025 at 10:45 PM
Privileged our mini-panel was selected for #ACNP2026 @acnporg.bsky.social. Grateful to join Drs. J. John Mann (Columbia), Alan Schatzberg (Stanford), Mina Rizk (Mount Sinai) and Yunyu Xiao (Cornell). Looking forward to the discussions ahead!
Proud to receive the American College of Neuropsychopharmacology (ACNP) Past Travel Awardee Funding, recognizing my ongoing research progress. #ACNP2025 @acnporg.bsky.social
August 11, 2025 at 11:42 PM
Proud to receive the American College of Neuropsychopharmacology (ACNP) Past Travel Awardee Funding, recognizing my ongoing research progress. #ACNP2025 @acnporg.bsky.social
Reposted by Igor D. Bandeira, MD, PhD
Research which is investigating why ketamine could be a good treatment for some people with depression, has discovered that the drug’s antidepressant effects involve the brain’s opioid system.
The study was supported by @nihr.bsky.social and the MRC.
www.maudsleybrc.nihr.ac.uk/posts/2025/j...
The study was supported by @nihr.bsky.social and the MRC.
www.maudsleybrc.nihr.ac.uk/posts/2025/j...
July 24, 2025 at 1:14 PM
Research which is investigating why ketamine could be a good treatment for some people with depression, has discovered that the drug’s antidepressant effects involve the brain’s opioid system.
The study was supported by @nihr.bsky.social and the MRC.
www.maudsleybrc.nihr.ac.uk/posts/2025/j...
The study was supported by @nihr.bsky.social and the MRC.
www.maudsleybrc.nihr.ac.uk/posts/2025/j...
Spoke with @peerj.bsky.social about my research after receiving 1st Prize for Best Poster at the Winter Conference on Brain Research 2025. #WCBR2025
peerj.com/blog/post/11...
Grateful for the chance to share what drives my work in interventional psychiatry.
peerj.com/blog/post/11...
Grateful for the chance to share what drives my work in interventional psychiatry.
June 9, 2025 at 10:08 PM
Spoke with @peerj.bsky.social about my research after receiving 1st Prize for Best Poster at the Winter Conference on Brain Research 2025. #WCBR2025
peerj.com/blog/post/11...
Grateful for the chance to share what drives my work in interventional psychiatry.
peerj.com/blog/post/11...
Grateful for the chance to share what drives my work in interventional psychiatry.
Thrilled to share that our book chapter has just been published as part of #Bipolar Disorder: An Evidence-Based Clinical Guide (Springer Nature, 2025).
May 22, 2025 at 7:35 PM
Thrilled to share that our book chapter has just been published as part of #Bipolar Disorder: An Evidence-Based Clinical Guide (Springer Nature, 2025).
I’m deeply grateful to the Anxiety and Depression Association of America (@adaaanxiety.bsky.social) for honoring me with the Alies Muskin Career Development Leadership Award this year. #ADAA2025
May 7, 2025 at 10:08 PM
I’m deeply grateful to the Anxiety and Depression Association of America (@adaaanxiety.bsky.social) for honoring me with the Alies Muskin Career Development Leadership Award this year. #ADAA2025
Reposted by Igor D. Bandeira, MD, PhD
The fourth annual Suicide Research Symposium (#SRS25) takes place THIS WEEK, Wednesday (April 23) through Friday (April 25)! Registration is still open for our free, virtual event. Links to register and see the conference platform are on our website: www.suicideresearchsymposium.com
SRS 2025
We are delighted to announce that the fourth annual Suicide Research Symposium will be taking place April 23-25, 2025. Like previous years, this Symposium will be free and take place virtually.
We ...
www.suicideresearchsymposium.com
April 21, 2025 at 2:41 PM
The fourth annual Suicide Research Symposium (#SRS25) takes place THIS WEEK, Wednesday (April 23) through Friday (April 25)! Registration is still open for our free, virtual event. Links to register and see the conference platform are on our website: www.suicideresearchsymposium.com
Happy to share that I have been selected for the Alies Muskin Career Development Leadership Award from the Anxiety and Depression Association of America (@adaaanxiety.bsky.social)! #ADAA2025
March 20, 2025 at 9:18 PM
Happy to share that I have been selected for the Alies Muskin Career Development Leadership Award from the Anxiety and Depression Association of America (@adaaanxiety.bsky.social)! #ADAA2025
It was a great honor to receive the New Investigator Award and share the preliminary data from our @afspnational.bsky.social study at the 21st Annual Meeting of the International Society for CNS Clinical Trials and Methodology in Washington, DC. #ISCTM2025
March 6, 2025 at 11:36 PM
It was a great honor to receive the New Investigator Award and share the preliminary data from our @afspnational.bsky.social study at the 21st Annual Meeting of the International Society for CNS Clinical Trials and Methodology in Washington, DC. #ISCTM2025
Honored to have been selected for the New Investigator Award from the International Society for CNS Clinical Trials and Methodology! This recognition aligns with my passion for advancing rigorous and innovative research methodologies to improve psychiatric care. #ISCTM #ISCTM2025
February 18, 2025 at 10:09 PM
Honored to have been selected for the New Investigator Award from the International Society for CNS Clinical Trials and Methodology! This recognition aligns with my passion for advancing rigorous and innovative research methodologies to improve psychiatric care. #ISCTM #ISCTM2025
I’m Still Here is a raw and unconventional exploration of identity, struggle, and reinvention. It reminds us that pain and adversity, rather than breaking us, can serve as catalysts for transformation.
February 9, 2025 at 5:20 AM
I’m Still Here is a raw and unconventional exploration of identity, struggle, and reinvention. It reminds us that pain and adversity, rather than breaking us, can serve as catalysts for transformation.
Happy to be in beautiful Tahoe as a Travel Fellowship Awardee at the Winter Conference on Brain Research! If you're curious about interventional psychiatry, the opioid properties of #ketamine, and treatment-resistant #depression, stop by my poster tomorrow (Board #31)! #WinterBrain #WCBR2025
January 27, 2025 at 11:02 PM
Happy to be in beautiful Tahoe as a Travel Fellowship Awardee at the Winter Conference on Brain Research! If you're curious about interventional psychiatry, the opioid properties of #ketamine, and treatment-resistant #depression, stop by my poster tomorrow (Board #31)! #WinterBrain #WCBR2025
Reposted by Igor D. Bandeira, MD, PhD
The NIH diversity supplement pages have all been pulled down. What is a diversity supplement and why should the public care? A diversity supplement is funding to help diversify the research workforce. You may be wondering, “so what?”. Let me explain. www.nigms.nih.gov/Pages/PageNo...
National Institute of General Medical Sciences
NIGMS supports basic research to understand biological processes and lay the foundation for advances in disease diagnosis, treatment, and prevention.
www.nigms.nih.gov
January 25, 2025 at 3:59 PM
The NIH diversity supplement pages have all been pulled down. What is a diversity supplement and why should the public care? A diversity supplement is funding to help diversify the research workforce. You may be wondering, “so what?”. Let me explain. www.nigms.nih.gov/Pages/PageNo...
Feeling deeply grateful after an incredible #ACNP2024! It was an honor to connect with inspiring colleagues, foster new connections, and reunite with lifelong friends. Special thanks to the #TravelAward2024 program for the invaluable mentorship and support. @acnporg.bsky.social
December 14, 2024 at 1:50 AM
Feeling deeply grateful after an incredible #ACNP2024! It was an honor to connect with inspiring colleagues, foster new connections, and reunite with lifelong friends. Special thanks to the #TravelAward2024 program for the invaluable mentorship and support. @acnporg.bsky.social
Our poster T16 on #ketamine for suicidal behavior in treatment-resistant #depression is up now at #ACNP2024! Let's discuss the comparative analysis of antisuicidal and antidepressant effects!
December 11, 2024 at 12:30 AM
Our poster T16 on #ketamine for suicidal behavior in treatment-resistant #depression is up now at #ACNP2024! Let's discuss the comparative analysis of antisuicidal and antidepressant effects!
Attending the recent panel on #suicideprevention at #ACNP2024 was truly thought-provoking. The dedication, innovative research, and shared commitment underscore the urgent need to advance effective interventions for this critical public health issue. @acnporg.bsky.social
December 10, 2024 at 11:43 PM
Attending the recent panel on #suicideprevention at #ACNP2024 was truly thought-provoking. The dedication, innovative research, and shared commitment underscore the urgent need to advance effective interventions for this critical public health issue. @acnporg.bsky.social
Hey #ACNP2024! Grateful to return for my 2nd year, this time as a Travel Awardee! I’m a postdoc at Stanford, working on interventional psychiatry clinical trials with #BrainStimulation and #Ketamine for depression. Hope to see you at my poster (T16) on 12/10!
December 8, 2024 at 1:01 AM
Hey #ACNP2024! Grateful to return for my 2nd year, this time as a Travel Awardee! I’m a postdoc at Stanford, working on interventional psychiatry clinical trials with #BrainStimulation and #Ketamine for depression. Hope to see you at my poster (T16) on 12/10!
Reposted by Igor D. Bandeira, MD, PhD
Honored to be part of this incredible group of travel awardees. #ACNP2024 #TravelAward2024
By popular demand, here is your #ACNP2024 Travel Awardee Starter pack!
A photo recap is included below - if you see anyone we've missed, please let us know! (we're still getting our bearings over here, so excuse any accidental oversights!)
go.bsky.app/N4AcAWv
A photo recap is included below - if you see anyone we've missed, please let us know! (we're still getting our bearings over here, so excuse any accidental oversights!)
go.bsky.app/N4AcAWv
December 5, 2024 at 8:45 PM
Honored to be part of this incredible group of travel awardees. #ACNP2024 #TravelAward2024
I am thrilled to announce that I have been honored with a Travel Fellowship Award to attend the 2025 Winter Conference on Brain Research!
November 28, 2024 at 12:04 AM
I am thrilled to announce that I have been honored with a Travel Fellowship Award to attend the 2025 Winter Conference on Brain Research!
Recruitment is ongoing for our study titled "Opiate Suicide Study in Patients with Major Depression" at Stanford University, sponsored by the American Foundation for Suicide Prevention.
November 18, 2024 at 11:08 PM
Recruitment is ongoing for our study titled "Opiate Suicide Study in Patients with Major Depression" at Stanford University, sponsored by the American Foundation for Suicide Prevention.
Excited to share that our paper, demonstrating how early changes in lassitude can predict response to Stanford Neuromodulation Therapy in treatment-resistant depression, has been published in npj Mental Health Research, part of the @natureportfolio.bsky.social.
www.nature.com/articles/s44...
www.nature.com/articles/s44...
October 30, 2024 at 2:25 AM
Excited to share that our paper, demonstrating how early changes in lassitude can predict response to Stanford Neuromodulation Therapy in treatment-resistant depression, has been published in npj Mental Health Research, part of the @natureportfolio.bsky.social.
www.nature.com/articles/s44...
www.nature.com/articles/s44...